About

Lirio focuses on improving patient engagement and health outcomes in the healthcare sector by utilizing behavioral science and artificial intelligence. The company provides solutions that encourage patients to schedule and attend important health screenings, such as mammograms and colorectal cancer screenings. Their main product, Precision Nudging, applies behavioral science principles to positively influence patient behavior and is integrated into healthcare providers' systems to keep patients engaged in their health. Unlike many competitors, Lirio addresses both external and internal barriers that prevent patients from attending appointments, which helps enhance healthcare delivery. The company's goal is to improve overall patient outcomes through effective engagement strategies, and it generates revenue through subscription services and partnerships with healthcare organizations.

Simplify's Take

What believers are saying

• The recent $150 million Series B funding round, led by Premji Invest, significantly boosts Lirio's financial resources for further innovation and market expansion.

What critics are saying

• The high valuation and substantial funding raise expectations for rapid growth and market penetration, which may be challenging to meet.

What makes Lirio unique

• Lirio's unique multi-omics platform offers unprecedented biological measurement capabilities, setting it apart from traditional healthcare analytics solutions.

Help us improve and share your feedback! Did you find this helpful?

YesNo